MedPath

Prospective Randomized Comparison of Zymar(Gatifloxacin) and Vigamox (Moxifloxacin) in Killing Conjunctival Bacterial Flora Following a One-hour Application

Not Applicable
Withdrawn
Conditions
Conjunctical Flora
Registration Number
NCT00466570
Lead Sponsor
Stanford University
Brief Summary

Topical ophthalmic antibiotics are common prescribed just prior to eye surgery to lower the risk of infection. Previous studies have suggested that antibiotics containing a preservative (Zymar) kill bacteria much quicker than those without a preservative (Vigamox). The purpose of this research is to compare how quickly to the two commonly prescribed antibiotics eliminate bacteria from the eye surface.

Detailed Description

Not available

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • Age- older than 50 years of age
  • Diagnosis- Cataract or had cataract surgery
Exclusion Criteria
  • Systemic or topical antibiotic treatment within 30 days
  • Use of systemic or topical steroids
  • Active ocular infection
  • Ocular surgery in the past 6 months
  • Allergy to fluoroquinolones

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Primary Outcome Measures
NameTimeMethod
Antibiotic killing of conjunctival bacterial flora 1 hour after application
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath